Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience (Q33405625)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience |
scientific article |
Statements
1 reference
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience (English)
1 reference
Robert L Fine
1 reference
Anthony P Gulati
1 reference
Stephen Schreibman
1 reference
Dawn A Tsushima
1 reference
Kelley B Mowatt
1 reference
Richard D Dinnen
1 reference
Yuehua Mao
1 reference
Peter D Stevens
1 reference
Beth Schrope
1 reference
John Allendorf
1 reference
James A Lee
1 reference
William H Sherman
1 reference
John A Chabot
1 reference
31 January 2013
1 reference
1 reference
71
1 reference
663-670
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference